Philipp Haselmayer

Philipp Haselmayer

Company: EMD Serono

Job title: Director - Immunology


BTK Inhibitor Evobrutinib: Translation of Preclinical Information into Clinical Data 11:50 am

The presentation will provide an overview of preclinical mode of action and pharmacodynamics studies of BTK inhibitor evobrutinib and how these translate into clinical relapsing multiple sclerosis studies.Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.